Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ)’s share price shot up 2.1% during mid-day trading on Monday . The stock traded as high as $37.75 and last traded at $37.55, with a volume of 225,275 shares. The stock had previously closed at $36.79.

Several research firms recently issued reports on ZLTQ. Piper Jaffray Cos. reissued an “overweight” rating and set a $40.00 target price on shares of Zeltiq Aesthetics in a research note on Monday, May 2nd. Brean Capital reissued a “buy” rating on shares of Zeltiq Aesthetics in a research note on Thursday, April 28th. Leerink Swann reissued an “outperform” rating and set a $48.00 target price (up previously from $43.00) on shares of Zeltiq Aesthetics in a research note on Thursday, August 11th. Maxim Group increased their target price on Zeltiq Aesthetics from $40.00 to $48.00 and gave the stock a “buy” rating in a research note on Tuesday, August 9th. Finally, Stifel Nicolaus reissued a “buy” rating and set a $38.00 target price on shares of Zeltiq Aesthetics in a research note on Friday, May 13th. Three investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $38.33.

The firm has a market cap of $1.49 billion and a price-to-earnings ratio of 56.50. The company’s 50-day moving average price is $33.69 and its 200-day moving average price is $28.17.

Zeltiq Aesthetics (NASDAQ:ZLTQ) last announced its quarterly earnings data on Monday, August 8th. The company reported ($0.12) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.05) by $0.07. The firm earned $89.50 million during the quarter, compared to analyst estimates of $79.68 million. During the same period in the prior year, the company posted $0.03 earnings per share. The firm’s revenue for the quarter was up 38.9% on a year-over-year basis. Analysts forecast that Zeltiq Aesthetics Inc. will post ($0.13) earnings per share for the current year.

In related news, VP Bradley Hauser sold 3,000 shares of Zeltiq Aesthetics stock in a transaction on Monday, July 11th. The stock was sold at an average price of $30.02, for a total value of $90,060.00. Following the transaction, the vice president now owns 47,184 shares in the company, valued at $1,416,463.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Mark J. Foley sold 10,000 shares of Zeltiq Aesthetics stock in a transaction on Monday, August 15th. The shares were sold at an average price of $37.26, for a total value of $372,600.00. Following the completion of the transaction, the insider now owns 311,274 shares in the company, valued at approximately $11,598,069.24. The disclosure for this sale can be found here.

A hedge fund recently raised its stake in Zeltiq Aesthetics stock. Wells Fargo & Company MN boosted its position in shares of Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) by 765.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 404,376 shares of the company’s stock after buying an additional 357,636 shares during the period. Wells Fargo & Company MN owned 1.04% of Zeltiq Aesthetics worth $11,537,000 as of its most recent SEC filing.

ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.